BeOne Medicines AG (HKG:6160)
Hong Kong · Delayed Price · Currency is HKD 190.50
-0.10 (-0.05%)
May 11, 2026, 4:08 PM HKT
BeOne Medicines AG Market Cap
BeOne Medicines AG has a market cap or net worth of 271.65 billion as of May 11, 2026. Its market cap has increased by 26.84% in one year.
Market Cap
271.65B
Enterprise Value
243.13B
Revenue
45.00B
Ranking
n/a
PE Ratio
67.54
Stock Price
190.50
Market Cap Chart
Since February 3, 2016, BeOne Medicines AG's market cap has increased from 6.70B to 271.65B, an increase of 3,956.39%. That is a compound annual growth rate of 43.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 271.65B | 3.81% |
| Dec 31, 2025 | 261.67B | 71.29% |
| Dec 31, 2024 | 152.77B | 4.09% |
| Dec 29, 2023 | 146.76B | -17.60% |
| Dec 30, 2022 | 178.11B | -17.96% |
| Dec 31, 2021 | 217.12B | 19.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innovent Biologics | 156.17B |
| WuXi Biologics | 135.14B |
| Akeso | 123.43B |
| Sichuan Kelun-Biotech Biopharmaceutical | 104.28B |
| Sino Biopharmaceutical | 96.89B |
| RemeGen | 70.69B |
| 3SBio | 55.81B |
| Biocytogen Pharmaceuticals (Beijing) | 42.65B |